ODE models for oncolytic virus dynamics

Journal of Theoretical Biology

Volumn 263, Issue 4, 2010, Pages 530-543

  Komarova, Natalia L ^a   Wodarz, Dominik ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer therapy; Differential equations; Mathematical modeling; Oncolytic virus

Indexed keywords

ONCOLYTIC VIRUS;

CANCER; NUMERICAL MODEL; TUMOR; VIRUS;

ARTICLE; CANCER GROWTH; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DYNAMICS; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; ONCOLYTIC VIROTHERAPY; PREDICTION; PRIORITY JOURNAL; VIROGENESIS; VIRUS REPLICATION;

COMPUTATIONAL BIOLOGY; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; VIRUS DISEASES; VIRUS REPLICATION;

EID: 77649340077     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.01.009     Document Type: Article

References (32)

1. Adam J.A., and Bellomo N. A Survey of Models for Tumor-Immune System Dynamics (1997), Birkhauser, Boston
2. Aghi M., and Martuza R.L. Oncolytic viral therapies-the clinical experience. Oncogene 24 (2005) 7802-7816
3. Anderson R.M., and May R.M. Infectious Diseases of Humans (1991), Oxford University Press, Oxford, England
4. Bajzer Z., Carr T., Josic K., Russell S.J., and Dingli D. Modeling of cancer virotherapy with recombinant measles viruses. J. Theor. Biol. 252 (2008) 109-122
5. Bell J.C. Oncolytic viruses: what's next?. Curr. Cancer Drug Targets 7 (2007) 127-131
6. Bell J.C., Lichty B., and Stojdl D. Getting oncolytic virus therapies off the ground. Cancer Cell 4 (2003) 7-11
7. Berezovskaya F.S., Novozhilov A.S., and Karev G.P. Population models with singular equilibrium. Math. Biosci. 208 (2007) 270-299
8. Crompton A.M., and Kirn D.H. From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development. Curr. Cancer Drug Targets 7 (2007) 133-139
9. Davis J.J., and Fang B. Oncolytic virotherapy for cancer treatment: challenges and solutions. J. Gene Med. 7 (2005) 1380-1389
10. Dingli D., Cascino M.D., Josic K., Russell S.J., and Bajzer Z. Mathematical modeling of cancer radiovirotherapy. Math. Biosci. 199 (2006) 55-78
11. Friedman A., Tian J.P., Fulci G., Chiocca E.A., and Wang J. Glioma virotherapy: effects of innate immune suppression and increased viral replication capacity. Cancer Res. 66 (2006) 2314-2319
12. Harrison D., Sauthoff H., Heitner S., Jagirdar J., Rom W.N., and Hay J.G. Wild-type adenovirus decreases tumor xenograft growth but despite viral persistence complete tumor responses are rarely achieved-deletion of the viral E1b-19-kD gene increases the viral oncolytic effect. Hum. Gene Ther. 12 (2001) 1323-1332
13. Kaplan J.M. Adenovirus-based cancer gene therapy. Curr. Gene Ther. 5 (2005) 595-605
14. Kelly E., and Russell S.J. History of oncolytic viruses: genesis to genetic engineering. Mol. Ther. 15 (2007) 651-659
15. Kirn D.H., and McCormick F. Replicating viruses as selective cancer therapeutics. Mol. Med. Today 2 (1996) 519-527
16. Lorence R.M., Pecora A.L., Major P.P., Hotte S.J., Laurie S.A., Roberts M.S., Groene W.S., and Bamat M.K. Overview of phase I studies of intravenous administration of PV701, an oncolytic virus. Curr. Opin. Mol. Ther. 5 (2003) 618-624
17. McCallum H., Barlow N., and Hone J. How should pathogen transmission be modelled?. Trends Ecol. Evol. 16 (2001) 295-300
18. McCormick F. Cancer-specific viruses and the development of ONYX-015. Cancer Biol. Ther. 2 (2003) S157-S160
19. McCormick F. Future prospects for oncolytic therapy. Oncogene 24 (2005) 7817-7819
20. Novozhilov A.S., Berezovskaya F.S., Koonin E.V., and Karev G.P. Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models. Biol. Direct 1 (2006) 6
21. Nowak M.A., and May R.M. Virus dynamics. Mathematical Principles of Immunology and Virology (2000), Oxford University Press, Oxford
22. O'Shea C.C. Viruses-seeking and destroying the tumor program. Oncogene 24 (2005) 7640-7655
23. Parato K.A., Senger D., Forsyth P.A., and Bell J.C. Recent progress in the battle between oncolytic viruses and tumours. Nat. Rev. Cancer 5 (2005) 965-976
24. Post D.E., Shim H., Toussaint-Smith E., and Van Meir E.G. Cancer scene investigation: how a cold virus became a tumor killer. Future Oncol. 1 (2005) 9247-9258
25. Roberts M.S., Lorence R.M., Groene W.S., and Bamat M.K. Naturally oncolytic viruses. Curr. Opin. Mol. Ther. 8 (2006) 314-321
26. Sigmund K. Kolmogorov and population dynamics. In: Charpentier E., Lesne A., and Nikolski N.K. (Eds). Kolmogorov's Heritage in Mathematics (2007), Springer, Berlin, Heidelberg 177-186
27. Vaha-Koskela, M.J., Heikkila, J.E., Hinkkanen, A.E., 2007. Oncolytic viruses in cancer therapy. Cancer Lett 254, 178-216
28. Wein L.M., Wu J.T., and Kirn D.H. Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. Cancer Res. 63 (2003) 1317-1324
29. Wodarz D. Viruses as antitumor weapons: defining conditions for tumor remission. Cancer Res. 61 (2001) 3501-3507
30. Wodarz D. Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents. Hum. Gene Ther. 14 (2003) 153-159
31. Wodarz D., and Komarova N.L. Computational Biology of Cancer. In: Lecture Notes and Mathematical Modeling (2005), World Scientific, Singapore
32. Wodarz D., and Komarova N.L. Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection. PLoS ONE 4 1 (2009) e4271